Delivery Order SPE2DB22D1106-SPE2DB25FELY0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,509.04 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This non-competitive delivery order carries a firm fixed price arrangement and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for 1,000 tablets of Losartan Potassium 100 mg at a ceiling value of $1,650.11. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's ability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,276.16 to AmerisourceBergen Drug Corp for 1,000 tablets of Losartan Potassium 100 mg, a commonly prescribed antihypertensive medication. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed-price terms and requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award includes no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- This is a $7,783.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,665,986 units of Losartan Potassium 100 mg tablets in 1,000-count sizes, with a completion date of April 21, 2023. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,080.19 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. This contract represents a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,000 units of Losartan Potassium 25 mg tablets. The contract has a completion date of February 26, 2024 and a potential value of $3,293.88. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 1,000 tablets of Losartan Potassium 50 mg, a pharmaceutical product, with a potential value of $2,120.76 and a completion date of January 3, 2024. The award was made on January 2, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a prime contractor that has...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,530 to Amerisourcebergen Drug Corporation for the supply of 1,000 tablets of 100mg losartan potassium. The delivery order was issued against an existing prime vendor contract held by Amerisourcebergen Corporation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania by August 31, 2023. As a major provider of pharmaceuticals to the Department of Defense globally, this order for a...
- AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) valued at $3,404.62 for 1,000 tablets of Losartan Potassium 25 mg, with a completion date of September 19, 2025. The contract was awarded on September 18, 2025, using firm fixed-price terms without set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FELY0Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,244.73 for 1,000 tablets of Losartan Potassium 100 mg, with an ultimate completion date of May 6, 2025. This non-set-aside, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Losartan potassium is a common antihypertensive medication used to treat high blood pressure in military and veteran populations. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. The company's extensive portfolio of competitively awarded delivery orders demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains, from generic medications to specialty pharmaceuticals and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/5/25 |